We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cancer Spread Takes More Than a Twist of Fate

By Biotechdaily staff writers
Posted on 13 Jul 2004
Cancer researchers have found that in order to metastasize, cancer cells must activate the gene that codes for the gene regulatory protein Twist. More...
Cancer cells lacking Twist can grow, but they cannot migrate to establish new tumors in distant tissues.

Investigators at the Whitehead Institute for Biomedical Research (Cambridge, MA, USA) used microarray technology to examine patterns of gene activation in metastatic and nonmetastatic cancer cells taken from mouse tumors. They reported in the June 25, 2004, issue of Cell that Twist, a gene regulator normally active in the developing embryo, was functioning in the metastatic cells but not in the nonmetastatic cells.

Further studies revealed that if the Twist gene was inactivated in a normally metastatic tumor, it failed to metastasize after being injected into naïve mice. Twist expression resulted in loss of E-cadherin-mediated cell-cell adhesion, activation of mesenchymal markers, and induction of cell motility. Lacking these influences, Twist-deficient cancers could grow but not spread.

Despite its obvious importance in the process of metastasis, Twist is not the whole story. Senior author Dr. Robert Weinberg, professor of biology at the Massachusetts Institute of Technology (Boston, MA, USA) said, "There are a number of other regulatory proteins that have been studied in other labs and have properties very similar to those of Twist. The other regulators undoubtedly will play important roles in other types of human metastatic cancer.”





Related Links:
Whitehead Institute for Biomedical Research

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.